TIGO
17.11.2021 23:02:08 CET | Business Wire | Press release
Tigo Energy Inc. , the solar industry’s worldwide leader in Flex MLPE (Module Level Power Electronics), announced today that Australia’s SCE Energy Solutions has deployed more than 7MW of monitored solar energy across 800 commercial, residential, and rural solar installations. SCE has leveraged the Tigo Energy Intelligence (EI) software platform to expand its service-oriented approach to maximize the benefits of the Tigo platform for its clients across Australia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211117006255/en/
SCE Energy Solutions uses the advanced chart pages for fleet management and kiosk view from Tigo Energy to enable two unique services for clients. Using the data provided by the EI software platform, SCE conducts weekly maintenance checks for system owners to ensure their systems are operating at peak performance. The kiosk view of the EI platform enables SCE to set up a screen for residential and commercial system owners through which they can showcase energy production and their commitment to renewable energy customers, colleagues, and friends.
“In the Tigo monitoring system we have the best available technology to improve the ROI for our customers, and it has a tremendously positive impact for the many businesses that previously wastes up to 50 percent of the energy they pay for,” said Jon De Martin, CEO and managing director at SCE Energy Solutions. “The kiosk feature of the Tigo Energy Intelligence system provides a powerful way for us to make solar visible, displaying the live energy statistics of our customers’ systems, which they can proudly showcase in public spaces at their business locations.”
SCE Energy Solutions has used Tigo TS4 Flex MLPE optimizers with remote module level monitoring since 2012. Since that time, SCE has implemented Tigo’s technology to service system owners throughout the Commonwealth of Australia, monitor their fleet remotely, and help customers highlight their investments in solar energy. Additionally, SCE provides critical feedback to Tigo for continuous improvement to the platform.
“We support installers’ revenue and strategic goals through a holistic approach to energy management, and SCE Energy Solutions is the ideal Tigo customer because they push the technological envelope and embrace innovation,” says Archie Roboostoff, software vice-president at Tigo Energy. “The SCE team exercises every aspect of our EI software solution to service their customers, reduce truck rolls, optimize energy generation, and maximize solar ROI for customers across Australia. We greatly appreciate the dedication SCE brings to their system owners.”
With more than 40,000 sites monitored worldwide, Tigo Energy processes 47,000 data points per second, resulting in almost a petabyte of monitoring and efficiency data. The platform is available on the internet and as a mobile application named Tigo EI on the Apple App Store and Google Play . To see the EI in action for SCE Energy Solutions, please see the unique insights SCE offers into a live solar site in Australia, here: https://ei.tigoenergy.com/p/C-O7B12J5FVS .
To learn more about Tigo Energy, visit www.tigoenergy.com .
About Tigo Energy
Tigo Energy is the worldwide leader in Flex MLPE (Module Level Power Electronics) with innovative solutions that increase solar energy production, decrease operating costs, and significantly enhance safety of solar energy systems. The Tigo TS4 platform maximizes the benefit of solar and provides customers with the most scalable, versatile, and reliable MLPE solution available. Tigo was founded in Silicon Valley in 2007 to accelerate the adoption of solar energy worldwide. Tigo systems operate on seven continents and produce gigawatt hours of reliable, clean, affordable, and safe solar energy daily. With a global team, Tigo Energy is dedicated to making the best MLPE on earth so more people can enjoy the benefits of solar. Find us online at www.tigoenergy.com .
About SCE Energy Solutions
SCE Energy Solutions is an award-winning sustainability business that prides itself on providing only the highest quality product and latest technologies available for their commercial, rural and residential customers. They have made it their mission to find technologies where clients can gain control of energy costs. This means developing a renewable energy system that is simple & easy to use with predictable payments and a 25-year warranty. We employ a unique five-step-plan: schedule a call, design the best possible system, install that system, get environmentally certified, and then SCE conducts weekly performance checks. They service all areas of Australia and are located in Concord NSW, Australia. For more information, go to www.sce-energysolutions.com.au .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211117006255/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom